Find information on thousands of medical conditions and prescription drugs.

Accolate

Zafirlukast is an oral leukotriene receptor antagonist (LTRA) for the maintenance treatment of asthma. Available as a tablet, it blocks the action of leukotriene C4 on its receptors, thus reducing constriction of the airways, build-up of mucus in the lungs and inflammation of the breathing passages.

Zafirlukast is marketed by AstraZeneca with the brand names Accolate, Accoleit, and Vanticon. It was the first LTRA to be marketed in the USA and is now approved in over 60 countries, including the UK, Japan, Italy, Spain, Canada, Brazil and China.

A

Acetylcholine chloride

Acetyldigitoxin

Alvircept sudotox

Aminocaproic acid

Aminoglutethimide

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Read more at Wikipedia.org

• [List your site here Free!]



	The asthma medication Accolate - Extra Bodyfit - Brief Article The asthma medication Accolate may be effective in treating early-phase capsular contracture, the most frequent problem following breast-implant surgery. From Muscle & Fitness/Hers, 12/1/02

	Accolate receives new pediatric indication - Brief Article - Statistical Data Included The Food and Drug Administration has approved a new pediatric formulation of AstraZeneca's asthma medication, Accolate (zafirlukast), for use in patients ... From Drug Store News, 10/25/99

	Zafirlukast in Clinical Practice Results of the Accolate Clinical Experience and Pharmacoepidemiology Trial in Patients with Asthma - ACCEPT BACKGROUND. Zafirlukast is an oral leukotriene receptor antagonist used in the treatment of patients with mild to moderate asthma. To investigate its ... From Journal of Family Practice, 6/1/99 by James P. Kemp

	Asthma drug linked to rare condition - Accolate, or zafirlukast, may cause Churg-Strauss syndrome - Brief Article New labeling for the ashtma treatment Accolate (zafirlukast) will warn doctors that the drug has been linked to Churg-Strauss syndrome, a rare and sometimes fatal condition. FDA learned that si From FDA Consumer, 11/1/97

	Zafirlukast treatment in patients with acute asthma There are 2 million emergency department visits and almost 500,000 hospital admissions annually in the United States because of acute asthma. Most patients ... From American Family Physician, 10/1/05 by Karl E. Miller

	Intermittent vs. Continuous therapy for mild asthma Clinical Question: Does continuous therapy with anti-inflammatory drugs improve outcomes for patients with mild persistent asthma? Setting: Outpatient ... From American Family Physician, 8/1/05 by Mark Ebell

	Treating allergies & asthma There are nearly as many medications out there to treat allergies and asthma as there are allergens. The chart below provides information on some of ... From National Women's Health Report, 8/1/05

	Intermittent therapy effective for mild persistent asthma Clinical Question Does continuous therapy with anti-inflammatory drugs improve outcomes for patients with mild persistent asthma? Study Design ... From Journal of Family Practice, 7/1/05

Home

Contact

Resources

ebay